IGEA Pharma Balance Sheet Health
Financial Health criteria checks 3/6
IGEA Pharma has a total shareholder equity of €9.7M and total debt of €1.1M, which brings its debt-to-equity ratio to 11%. Its total assets and total liabilities are €11.4M and €1.7M respectively.
Key information
11.0%
Debt to equity ratio
€1.06m
Debt
Interest coverage ratio | n/a |
Cash | €94.70k |
Equity | €9.67m |
Total liabilities | €1.68m |
Total assets | €11.35m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 0AAX's short term assets (€1.2M) exceed its short term liabilities (€1.1M).
Long Term Liabilities: 0AAX's short term assets (€1.2M) exceed its long term liabilities (€570.0K).
Debt to Equity History and Analysis
Debt Level: 0AAX's net debt to equity ratio (10%) is considered satisfactory.
Reducing Debt: Insufficient data to determine if 0AAX's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Insufficient data to determine if 0AAX has enough cash runway based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if 0AAX has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.